Clinical Trial Update: Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the efficacy and safety of QHRD106 Injection in acute ischemic stroke, which is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• QHRD106 Injection (QHRD106)

Snippet

Sponsor: Changzhou Qianhong Bio-pharma Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING